Delivering value to healthcare and life sciences stakeholders
by expanding access and improving outcomes.
For more than 25 years, Dr. Miller has been helping people and organizations accelerate health and healthcare improvements. As a trusted and knowledgeable expert, he has worked with large and small organizations to achieve their objectives.
Dr. Miller helps clients achieve their desired results and outcomes by analyzing clinical, scientific, economic, stakeholder, and political aspects of healthcare and life sciences issues, and then synthesizing and translating that information into knowledge-based strategies and executable tactics. [See Case Studies]
Projects have involved new financing and delivery models, reimbursement practices, government programs, telemedicine, IP protection, and innovations for specific clinical conditions and populations to achieve measurable clinical and economic outcomes.
Data » Knowledge » Results »
Structures » Processes » Outcomes »
Understanding different stakeholder perspectives is crucial for healthcare and life sciences initiatives. Dr. Miller integrates the roles, concerns, and needs of patients, clinicians, provider organizations, businesses, local and national governments, and community-based organizations into strategies and tactics for improving health, healthcare markets, and outcomes.
Reviews from Client Engagements:
“Amazing is all I can say. You are the first person who could speak to [the] ACA in [ways] which people listened and engaged. You kept the room full!.” Beth Battaglino, CEO HealthyWomen
“Thank you for all the work you and your team at NGA did to facilitate the event in Nashville. We will long remember the NGA-NAM summit as a seminal event. I look forward to further work together.” John Dreyzehner, Commissioner, Tennessee Department of Health
“I wish to add my thanks once again for the exceptional effort reflected in your February 19, 2015, presentation to our financial policy students. I understand from [Professor] Barry Clendenin that the specific attention to Medicaid, Medicare and the Affordable Care Act’s costs and benefits offered valuable and timely perspectives to our students as they analyze financial questions affecting the Federal and State Governments. We appreciate the quality and thoroughness of your lectures and the enthusiasm reflected in your interactions with the class members. We are grateful for you continuing support for our students, and the public policy experience you bring to our classroom.” Mark Rozell, Acting Dean, George Mason University School of Policy, Government, and International Affairs
“…“Mike, the [Culture of Health] talk went well. It fits in with the [Global Forum on Leadership, Learning and Strategic Change’s] Action Learning process…… Thanks again.” Thomas M. Gorrie PhD, Robert Wood Johnson Foundation Board Member, Former Johnson & Johnson V.P. of Government Affairs and Policy
“Your comments about the role of increased treatment utilization in driving the need for comprehensive Medicare reform were very important and underscored for our group the complexity of the problem facing the healthcare system.” Connie Trump, Associate Director, Knoll, and Co-Chair AACE Corporate Advisory Board
“…thank you for your contribution to our panel discussion at the HMO Alliance meeting. This session was well received by our CEOs, Medical Directors and Pharmacy Directors…. our sincere thanks for helping to make this meeting one of our best ever.” Dana McCormick, Director of Care Innovations, The HMO Alliance
“Your insight into the prescription drug issues will be of great assistance to the Committee as we work to address this national problem in a comprehensive manner.” John D. Rockefeller IV, United States Senator
“The majority of our audience members came prepared to dispute your position on the cost of prescription drugs. You made a most effective presentation, with concrete facts, and gave our audience a lot to think about.” Arima Freas, President, Manhattan Borough-Wide Inter-Agency Council On Aging
“Mike is an excellent writer and a very good editor.”Steven Grossman, Executive Director, The FDA Alliance (now the Alliance for a Stronger FDA)
“Thank you for the fabulous grand rounds at Caritas Carney Hospital yesterday. You obviously put a great deal of time and thought into presenting to us; your lecture was a remarkable overview of so many issues affecting our health care system today! You have a great mind to be able to have both the comprehension to understand these concepts, and the ability to synthesize numerous trends and ideas into an integrated presentation. Two of the best compliments to you are 1) docs stayed until the end of grand rounds and 2) our new insights inspired conversations and debates in hospital halls and offices all day long!” Mary Lou Ashur, MD